-
1
-
-
0017717778
-
"Off period" dystonia and "on period" choreoathetosis in levodopatreated patients with Parkinson's disease
-
Lees AJ, Shaw KM, Stern GM. "Off period" dystonia and "on period" choreoathetosis in levodopatreated patients with Parkinson's disease. Lancet. 1977;2(8046):1034.
-
(1977)
Lancet
, vol.2
, Issue.8046
, pp. 1034
-
-
Lees, A.J.1
Shaw, K.M.2
Stern, G.M.3
-
2
-
-
10344236071
-
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias
-
de la Fuente-Fernández R, et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain. 2004;127(12):2747-2754.
-
(2004)
Brain
, vol.127
, Issue.12
, pp. 2747-2754
-
-
De La Fuente-Fernández, R.1
-
3
-
-
0014930392
-
L-Dopainduced release of cerebral monoamines
-
Ng KY, Chase TN, Colburn RW, Kopin IJ. L-Dopainduced release of cerebral monoamines. Science. 1970;170(3953):76-77.
-
(1970)
Science
, vol.170
, Issue.3953
, pp. 76-77
-
-
Ng, K.Y.1
Chase, T.N.2
Colburn, R.W.3
Kopin, I.J.4
-
4
-
-
0015207733
-
Effects of L-dopa on efflux of cerebral monoamines from synaptosomes
-
Ng KY, Colburn RW, Kopin IJ. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes. Nature. 1971;230(5292):331-332.
-
(1971)
Nature
, vol.230
, Issue.5292
, pp. 331-332
-
-
Ng, K.Y.1
Colburn, R.W.2
Kopin, I.J.3
-
5
-
-
0033601926
-
Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats
-
Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport. 1999;10(3):631-634.
-
(1999)
Neuroreport
, vol.10
, Issue.3
, pp. 631-634
-
-
Tanaka, H.1
Kannari, K.2
Maeda, T.3
Tomiyama, M.4
Suda, T.5
Matsunaga, M.6
-
6
-
-
37549029102
-
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
-
Kish SJ, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain. 2008;131(1):120-131.
-
(2008)
Brain
, vol.131
, Issue.1
, pp. 120-131
-
-
Kish, S.J.1
-
7
-
-
77955844658
-
Staging of serotonergic dysfunction in Parkinson's disease: An in vivo 11C-DASB PET study
-
Politis M, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis. 2010;40(1):216-221.
-
(2010)
Neurobiol Dis
, vol.40
, Issue.1
, pp. 216-221
-
-
Politis, M.1
-
8
-
-
0022253616
-
In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat
-
Schmidt CJ, Lovenberg W. In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat. Neurosci Lett. 1985;59(1):9-14.
-
(1985)
Neurosci Lett
, vol.59
, Issue.1
, pp. 9-14
-
-
Schmidt, C.J.1
Lovenberg, W.2
-
9
-
-
0346422386
-
Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake
-
Saldaña SN, Barker EL. Temperature and 3,4- methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake. Neurosci Lett. 2004;354(3):209-212.
-
(2004)
Neurosci Lett
, vol.354
, Issue.3
, pp. 209-212
-
-
Saldaña, S.N.1
Barker, E.L.2
-
10
-
-
20144378889
-
Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA
-
Maeda T, Nagata K, Yoshida Y, Kannari K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain Res. 2005;1046(1-2):230-233.
-
(2005)
Brain Res
, vol.1046
, Issue.1-2
, pp. 230-233
-
-
Maeda, T.1
Nagata, K.2
Yoshida, Y.3
Kannari, K.4
-
11
-
-
33646822115
-
Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters
-
Kannari K, Shen H, Arai A, Tomiyama M, Baba M. Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters. Neurosci Lett. 2006;402(1-2):62-65.
-
(2006)
Neurosci Lett
, vol.402
, Issue.1-2
, pp. 62-65
-
-
Kannari, K.1
Shen, H.2
Arai, A.3
Tomiyama, M.4
Baba, M.5
-
12
-
-
34447627504
-
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
-
Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain. 2007;130(7):1819-1833.
-
(2007)
Brain
, vol.130
, Issue.7
, pp. 1819-1833
-
-
Carta, M.1
Carlsson, T.2
Kirik, D.3
Björklund, A.4
-
13
-
-
34547115255
-
The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy
-
Eskow KL, Gupta V, Alam S, Park JY, Bishop C. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav. 2007;87(3):306-314.
-
(2007)
Pharmacol Biochem Behav
, vol.87
, Issue.3
, pp. 306-314
-
-
Eskow, K.L.1
Gupta, V.2
Alam, S.3
Park, J.Y.4
Bishop, C.5
-
14
-
-
33947302427
-
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
-
Dekundy A, Lundblad M, Danysz W, Cenci MA. Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model. Behav Brain Res. 2007;179(1):76-89.
-
(2007)
Behav Brain Res
, vol.179
, Issue.1
, pp. 76-89
-
-
Dekundy, A.1
Lundblad, M.2
Danysz, W.3
Cenci, M.A.4
-
15
-
-
58149107401
-
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPAinduced dyskinesia
-
Muñoz A, et al. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPAinduced dyskinesia. Brain. 2008;131(12):3380-3394.
-
(2008)
Brain
, vol.131
, Issue.12
, pp. 3380-3394
-
-
Muñoz, A.1
-
16
-
-
56249141071
-
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat
-
Dupre KB, Eskow KL, Barnum CJ, Bishop C. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. Neuropharmacology. 2008;55(8):1321-1328.
-
(2008)
Neuropharmacology
, vol.55
, Issue.8
, pp. 1321-1328
-
-
Dupre, K.B.1
Eskow, K.L.2
Barnum, C.J.3
Bishop, C.4
-
17
-
-
77349086589
-
L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: Temporal and quantitative relationship to the expression of dyskinesia
-
Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. J Neurochem. 2010;112(6):1465-1476.
-
(2010)
J Neurochem
, vol.112
, Issue.6
, pp. 1465-1476
-
-
Lindgren, H.S.1
Andersson, D.R.2
Lagerkvist, S.3
Nissbrandt, H.4
Cenci, M.A.5
-
18
-
-
84857195565
-
Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning
-
Nahimi A, et al. Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning. J Neurochem. 2012;120(5):806-817.
-
(2012)
J Neurochem
, vol.120
, Issue.5
, pp. 806-817
-
-
Nahimi, A.1
-
19
-
-
84881556666
-
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
-
Bezard E, et al. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov Disord. 2013;28(8):1088-1096.
-
(2013)
Mov Disord
, vol.28
, Issue.8
, pp. 1088-1096
-
-
Bezard, E.1
-
20
-
-
0036895554
-
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study
-
Khan NL, et al. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol. 2002;52(6):849-853.
-
(2002)
Ann Neurol
, vol.52
, Issue.6
, pp. 849-853
-
-
Khan, N.L.1
-
21
-
-
0033955756
-
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
-
de la Fuente-Fernández R, et al. Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations. J Neural Transm. 2000;107(1):49-57.
-
(2000)
J Neural Transm
, vol.107
, Issue.1
, pp. 49-57
-
-
De La Fuente-Fernández, R.1
-
22
-
-
78249271694
-
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
-
Rylander D, et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol. 2010;68(5):619-628.
-
(2010)
Ann Neurol
, vol.68
, Issue.5
, pp. 619-628
-
-
Rylander, D.1
-
23
-
-
0035960558
-
Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
-
Bibbiani F, Oh JD, Chase TN. Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology. 2001;57(10):1829-1834.
-
(2001)
Neurology
, vol.57
, Issue.10
, pp. 1829-1834
-
-
Bibbiani, F.1
Oh, J.D.2
Chase, T.N.3
-
24
-
-
26444586231
-
Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease
-
Bara-Jimenez W, et al. Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease. Mov Disord. 2005;20(8):932-936.
-
(2005)
Mov Disord
, vol.20
, Issue.8
, pp. 932-936
-
-
Bara-Jimenez, W.1
-
25
-
-
33847757879
-
Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo-controlled trial
-
Goetz CG, et al. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial. Mov Disord. 2007;22(2):179-186.
-
(2007)
Mov Disord
, vol.22
, Issue.2
, pp. 179-186
-
-
Goetz, C.G.1
-
26
-
-
46149088212
-
Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat
-
Dupre KB, et al. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat. Psychopharmacology. 2008;199(1):99-108.
-
(2008)
Psychopharmacology
, vol.199
, Issue.1
, pp. 99-108
-
-
Dupre, K.B.1
-
27
-
-
77955617871
-
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants
-
Politis M, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med. 2010;2(38):38ra46.
-
(2010)
Sci Transl Med
, vol.2
, Issue.38
-
-
Politis, M.1
-
28
-
-
80052971467
-
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
-
Politis M, et al. Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord. 2011;26(11):1997- 2003.
-
(2011)
Mov Disord
, vol.26
, Issue.11
, pp. 1997-2003
-
-
Politis, M.1
-
29
-
-
78649534741
-
Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?
-
Politis M. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next? BMC Med. 2010;8:80.
-
(2010)
BMC Med
, vol.8
, pp. 80
-
-
Politis, M.1
-
31
-
-
0028057911
-
Buspirone in levodopa-induced dyskinesias
-
Bonifati V, Fabrizio E, Cipriani R, Vanacore N, Meco G. Buspirone in levodopa-induced dyskinesias. Clin Neuropharmacol. 1994;17(1):73-82.
-
(1994)
Clin Neuropharmacol
, vol.17
, Issue.1
, pp. 73-82
-
-
Bonifati, V.1
Fabrizio, E.2
Cipriani, R.3
Vanacore, N.4
Meco, G.5
-
32
-
-
0023897645
-
Peripheral pharmacokinetic parameters of levodopa/carbidopa and the on-off phenomenon in parkinsonian patients
-
Rainero I, et al. Peripheral pharmacokinetic parameters of levodopa/carbidopa and the on-off phenomenon in parkinsonian patients. Ital J Neurol Sci. 1988;9(3):225-259.
-
(1988)
Ital J Neurol Sci
, vol.9
, Issue.3
, pp. 225-259
-
-
Rainero, I.1
-
33
-
-
0031933827
-
Concentrations and effects of buspirone are considerably reduced by rifampicin
-
Lamberg TS, Kivistö KT, Neuvonen PJ. Concentrations and effects of buspirone are considerably reduced by rifampicin. Br J Clin Pharmacol. 1998; 45(4):381-385.
-
(1998)
Br J Clin Pharmacol
, vol.45
, Issue.4
, pp. 381-385
-
-
Lamberg, T.S.1
Kivistö, K.T.2
Neuvonen, P.J.3
-
34
-
-
55749087155
-
Hypothalamic involvement in Huntington's disease: An in vivo PET study
-
Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain. 2008; 131(11):2860-2869.
-
(2008)
Brain
, vol.131
, Issue.11
, pp. 2860-2869
-
-
Politis, M.1
Pavese, N.2
Tai, Y.F.3
Tabrizi, S.J.4
Barker, R.A.5
Piccini, P.6
-
35
-
-
0031279782
-
Parametric imaging of ligand-receptor binding in PET using a simplified reference region model
-
Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6(4):279-287.
-
(1997)
Neuroimage
, vol.6
, Issue.4
, pp. 279-287
-
-
Gunn, R.N.1
Lammertsma, A.A.2
Hume, S.P.3
Cunningham, V.J.4
-
36
-
-
13844317450
-
Regional distribution of serotonin transporter protein in postmortem human brain: Is the cerebellum a SERT-free brain region?
-
Kish SJ, et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol. 2005;32(2):123-128.
-
(2005)
Nucl Med Biol
, vol.32
, Issue.2
, pp. 123-128
-
-
Kish, S.J.1
-
37
-
-
0029743481
-
Distribution volume ratios without blood sampling from graphical analysis of PET data
-
Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16(5):834-840.
-
(1996)
J Cereb Blood Flow Metab
, vol.16
, Issue.5
, pp. 834-840
-
-
Logan, J.1
Fowler, J.S.2
Volkow, N.D.3
Wang, G.J.4
Ding, Y.S.5
Alexoff, D.L.6
-
38
-
-
0035200087
-
Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: Modeling strategies
-
Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab. 2001;21(11):1342- 1353.
-
(2001)
J Cereb Blood Flow Metab
, vol.21
, Issue.11
, pp. 1342-1353
-
-
Ginovart, N.1
Wilson, A.A.2
Meyer, J.H.3
Hussey, D.4
Houle, S.5
-
39
-
-
0034857407
-
Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data
-
Turkheimer FE, Smith CB, Schmidt K. Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data. Neuroimage. 2001;13(5):920-930.
-
(2001)
Neuroimage
, vol.13
, Issue.5
, pp. 920-930
-
-
Turkheimer, F.E.1
Smith, C.B.2
Schmidt, K.3
|